These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35071276)
1. Vitreomacular Interface Abnormalities in Myopic Foveoschisis: Correlation With Morphological Features and Outcome of Vitrectomy. Fang D; Wang L; Chen L; Liang J; Li K; Mao X; Xie T; Zhang S Front Med (Lausanne); 2021; 8():796127. PubMed ID: 35071276 [No Abstract] [Full Text] [Related]
3. Clinical characteristics of patients with epiretinal membrane-Foveoschisis. Hetzel A; Neubauer J; Gelisken F Graefes Arch Clin Exp Ophthalmol; 2023 Jun; 261(6):1579-1585. PubMed ID: 36576570 [TBL] [Abstract][Full Text] [Related]
4. [Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy]. Maier M; Abraham S; Frank C; Lohmann CP; Feucht N Ophthalmologe; 2017 Feb; 114(2):148-154. PubMed ID: 27444007 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of non-fovea-sparing ILM peeling for symptomatic myopic foveoschisis with and without macular hole. Al-Badawi AH; Abdelhakim MASE; Macky TA; Mortada HA Br J Ophthalmol; 2019 Feb; 103(2):257-263. PubMed ID: 29712637 [TBL] [Abstract][Full Text] [Related]
6. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Koizumi H; Spaide RF; Fisher YL; Freund KB; Klancnik JM; Yannuzzi LA Am J Ophthalmol; 2008 Mar; 145(3):509-517. PubMed ID: 18191099 [TBL] [Abstract][Full Text] [Related]
7. Vitrectomy With Silicone Oil Tamponade and Without Internal Limiting Membrane Peeling for the Treatment of Myopic Foveoschisis With High Risk of Macular Hole Development. Yao Y; Qu J; Shi X; Hu J; Hou J; Miao H; Cheng Y; Zhao M Front Med (Lausanne); 2021; 8():648540. PubMed ID: 34124090 [No Abstract] [Full Text] [Related]
8. Changes in choroidal thickness after vitrectomy for epiretinal membrane combined with vitreomacular traction. Kang EC; Lee KH; Koh HJ Acta Ophthalmol; 2017 Aug; 95(5):e393-e398. PubMed ID: 27229756 [TBL] [Abstract][Full Text] [Related]
9. A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit). Stalmans P Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):617-28. PubMed ID: 26899900 [TBL] [Abstract][Full Text] [Related]
10. Postoperative eccentric macular holes after surgery for vitreomacular interface diseases. Yetkin E; Citirik M; Teke MY; Kiziltoprak H Int Ophthalmol; 2020 Mar; 40(3):591-596. PubMed ID: 31720973 [TBL] [Abstract][Full Text] [Related]
11. Vitreomacular traction in diabetic retinopathy. Hsieh YT; Yang CM Jpn J Ophthalmol; 2024 Jan; 68(1):12-18. PubMed ID: 38001367 [TBL] [Abstract][Full Text] [Related]
12. Highly reflective foveal region in optical coherence tomography in eyes with vitreomacular traction or epiretinal membrane. Tsunoda K; Watanabe K; Akiyama K; Usui T; Noda T Ophthalmology; 2012 Mar; 119(3):581-7. PubMed ID: 22115711 [TBL] [Abstract][Full Text] [Related]
13. Internal limiting membrane peeling combined with silicone oil or air tamponade for highly myopic foveoschisis. Deng J; Sun WT; Gong K; Wang LP; Li FZ Int J Ophthalmol; 2024; 17(6):1079-1085. PubMed ID: 38895672 [TBL] [Abstract][Full Text] [Related]
14. Surgical outcomes in patients with lamellar macular holes selected based on the optical coherence tomography consensus definition. Chehaibou I; Philippakis E; Mané V; Lavia C; Couturier A; Gaudric A; Tadayoni R Int J Retina Vitreous; 2021 Apr; 7(1):31. PubMed ID: 33849663 [TBL] [Abstract][Full Text] [Related]